Dr Delia C Sykes, MD in Albemarle, NC - Anesthesiology

Dr Delia C Sykes, MD is a Anesthesiology physician based in Albemarle, North Carolina. Dr Delia C Sykes is licensed to practice in North Carolina (license number 27149) and her current practice location is 301 Yadkin St, Anesthesia Dept, Albemarle, North Carolina. She can be reached at her office (for appointments etc.) via phone at (704) 984-0000.

NPI number for Dr Delia C Sykes is 1851370035 and her current mailing address is Po Box 751589, Charlotte, North Carolina. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1851370035.

Contact Information

	Dr Delia C Sykes, MD
	301 Yadkin St, Anesthesia Dept, Albemarle, NC 28001-3441
	(704) 984-0000
	Not Available

Physician's Profile

Full Name	Dr Delia C Sykes
Gender	Female
Speciality	Anesthesiology
Location	301 Yadkin St, Albemarle, North Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1851370035
Provider Enumeration Date: 01/16/2006
Last Update Date: 10/05/2007

Medical Identifiers

Medical identifiers for Dr Delia C Sykes such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1851370035	NPI	-	NPPES
8926479	Medicaid	NC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	27149 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Delia C Sykes is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Delia C Sykes, MD Po Box 751589, Charlotte, NC 28275-1589 Ph: (706) 860-2701	Dr Delia C Sykes, MD 301 Yadkin St, Anesthesia Dept, Albemarle, NC 28001-3441 Ph: (704) 984-0000

News Archive

Statins may provide benefits to patients who underwent percutaneous coronary intervention

Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.

TRANSFUSION publishes positive results from CryoStor collaborative research

BioLife Solutions, Inc., a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, today announced that TRANSFUSION, the foremost publication in the world for new information regarding transfusion medicine, has published a peer-reviewed journal article reporting positive results of collaborative research on CryoStor, BioLife's serum-free, protein-free cryopreservation freeze media.

MSMB offers $18 per share for Amag acquisition

MSMB Capital Management today announced that it has made a proposal to the Board of Directors of Amag Pharmaceuticals Inc. to acquire all of the outstanding shares of common stock of Amag for $18 per share in cash or an aggregate of $378 million.

Neighborhood quality may affect a person's longevity after heart attack

Black patients from disadvantaged neighborhoods were significantly more likely to die within five years of surviving a heart attack compared with Black heart attack patients from wealthier neighborhoods and white patients of any socioeconomic means who survive a heart attack, according to a study being presented at the American College of Cardiology's 70th Annual Scientific Session.

Coating implants with certain 'activator' can prevent S. aureus infection

Biofilms frequently coat the surfaces of catheters, and of various medical implants and prostheses, where they can cause life-threatening infections. New research at the Sahlgrenska Academy show that coating implants with a certain "activator" can prevent Staphylococcus aureus, the leading cause of hospital-acquired infections, from forming biofilms.

Dr Delia C Sykes, MD - Anesthesiology in Albemarle, NC